The Top Barrier To AI In Drug Discovery May Surprise You

Chief Growth Officer at BenchSci, helping more scientists plan successful experiments with AI-driven reagent intelligence. Naheed Kurji was pitching his AI drug discovery startup, Cyclica. The audience was a large group of scientists. It included senior scientists and heads of computational drug discovery and chemistry. These were the right people. Kurji hit the key points and stayed on message.